Abstract:Objective:To explore the possible pathways and regulatory mechanism of TGFβ1induced transdifferentiation of derma fibroblasts(FB) into myofibroblasts. Methods: Mice Wildtype and Smad3 knockout(Smad3 KO) derma FB were divided into 9 groups,namely,A:Wildtype FB; B:Wildtype FB+TGFβ1; C:Wildtype FB+SB431542; D:Wildtype FB+SB431542+TGFβ1; E:Smad3 KO FB; F:Smad3 KO FB+TGFβ1; G:Wildtype FB+SB203580+TGFβ1; H:Wildtype FB+PD98059+TGFβ1; and I:Wildtype FB+SP600125+TGFβ1. After synchronization treatment,the cells were treated with TGFβ1 with or without pretreatment with above mentioned kinases inhibitors. Then the cells were collected for RNA extraction and the expression of αSMA was detected by real time quantitative RTPCR; some cells were analyzed by single cell RTPCR to test the positive expression rate of αSMA.Results: The expression and positive rate of αSMA in SB431542 group and Smad3 knockout group were significantly increased(group E vs. group A;group D vs. group C;group F vs. group E,P<0.01) and those in SP600125 group and SB203580 group were significantly inhibited(group G and I vs. group B,P<0.05). Conclusion: In TGFβ1induced derma fibroblasts transdifferentiation into myofibroblasts,Smad3 pathway plays a negative regulatory role and p38/MAPK and JNK/MAPK pathway play a positive regulatory role.